FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Together, our results demonstrated that target gene mutation of FKRP by CRISPR/Cas9‐mediated genome editing could recapitulate pathological hallmarks of dystroglycanopathy in human iPSC‐derived cortical neurons.